Amy Hankin

658 citations
28 papers · 210 indexed · h-index 7
Topics
Prostate Cancer Treatment and Research (24 papers)Cancer Immunotherapy and Biomarkers (16 papers)Immunotherapy and Immune Responses (9 papers)
Journals
Journal of Clinical OncologySHILAP Revista de lepidopterologíaCancer
Partner nations
United StatesNew Zealand

In The Last Decade

Amy Hankin

26 papers receiving 208 citations

Peers

Amy Hankin
Comparison fields: 5 of 30
  • Oncology 161
  • Pulmonary and Respiratory Medicine 78
  • Molecular Biology 77
  • Immunology 58
  • Cancer Research 41
Replace Thiru Prasanna with:
Thiru Prasanna Australia
Anke Van Lierop Germany
Margareta Heby Sweden
Jinzhi Lai China
Elke Veltrup Germany
Elise Ballot France
Elisa Minenza Italy
Mallika Dhawan United States
Daiyuan Ma China
Joseph M. Obeid United States
Amy Hankin relative to Thiru Prasanna Australia Thiru Prasanna's profile →
Citations per field
00.5×3.4×
Thiru Prasanna · 1×
Citations per year

Countries citing papers authored by Amy Hankin

Since Specialization
Citations

This map shows the geographic impact of Amy Hankin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amy Hankin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amy Hankin more than expected).

Fields of papers citing papers by Amy Hankin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amy Hankin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amy Hankin. The network helps show where Amy Hankin may publish in the future.

Co-authorship network of co-authors of Amy Hankin

This figure shows the co-authorship network connecting the top 25 collaborators of Amy Hankin. A scholar is included among the top collaborators of Amy Hankin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amy Hankin. Amy Hankin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 1
4 1
5 3
6 1
7 3
8 1
9 3
10 1
11 6
12 6
13 3
14 1
15 54
16 5
17 1
18 18
19 18
20 15

About Amy Hankin

Amy Hankin is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Immunology, having authored 28 papers that have together received 210 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (24 papers), Cancer Immunotherapy and Biomarkers (16 papers) and Immunotherapy and Immune Responses (9 papers). The work is most often cited by research in Oncology (161 citations), Immunology (58 citations) and Cancer Research (41 citations). Amy Hankin has collaborated with scholars based in United States and New Zealand. Frequent co-authors include Ravi A. Madan, Louis M. Weiner, Michael J. Pishvaian, John L. Marshall, Jonathan R. Brody, Jimmy J. Hwang, Aiwu Ruth He, James L. Gulley, Fatima Karzai and William L. Dahut. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026